Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04182776 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fragility Fractures of the Pelvis (FFP)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jun 2026 to Jul 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 10 of 10 sites
    v16
  2. 2 versions Re-verified since Dec 11, 2024, no change to tracked fieldsv14-v15
  3. Primary and study completion dates: Sep 2024 to Jun 2026v13
  4. Site details revised at 3 of 10 sitesv12
  5. Primary completion date: Sep 2023 to Sep 2024v11
Show 9 earlier versionsHide 9 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2022 to Mar 1, 2022
    • Site details revised at 10 of 10 sites
    v10
  2. Start date: Dec 2021 to Feb 2022v9
  3. Start date: Sep 2021 to Dec 2021v8
  4. Start date: Apr 2021 to Sep 2021v7
  5. Start date: Jan 2021 to Apr 2021v6
  6. Start date: Dec 2020 to Jan 2021v5
  7. Start date: Jul 2020 to Dec 2020v4
  8. Lead sponsor: AO Clinical Investigation and Publishing Documentation to AO Innovation Translation Center
    • Start date: Apr 2020 to Jul 2020
    v3
  9. Primary completion date: Jul 2023 to Sep 2023
    • Study completion date: Jul 2024 to Sep 2024
    • Start date: Mar 2020 to Apr 2020
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s, radiological outcomes, and anticipated or procedure-related adverse events (i.e. complications).
Trial Details
NCT Number NCT04182776
Lead Sponsor AO Innovation Translation Center
Conditions
(from sponsor)		 Pelvic Fracture
Related terms Hip Fractures
Enrollment 420 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov